Previously, we showed that PHB-repressed AR activity and androgen-stimulated growth of LNCaP prostate cancer cells and that RNA interference-mediated knockdown had the opposite effects, and sensitised cells to low levels of androgens, both in vitro and in vivo. This evidence concerns the gene AR and prostate carcinoma.